Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation

mBio

Volumn 7, Issue 6, 2016, Pages

  Staley, Christopher ^a   Kelly, Colleen R ^b,c   Brandt, Lawrence J ^d   Khoruts, Alexander ^a,e   Sadowsky, Michael J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDETES; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CONVALESCENCE; ENGRAFTMENT; FECAL MICROBIOTA TRANSPLANTATION; FIRMICUTES; HUMAN; MICROBIAL COMMUNITY; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; ADULT; AGED; BAYES THEOREM; CLINICAL TRIAL (TOPIC); CLOSTRIDIUM INFECTIONS; DIARRHEA; FECES; FEMALE; HIGH THROUGHPUT SEQUENCING; INTESTINE FLORA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; NORMAL HUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RECURRENT DISEASE; REMISSION; STANDARDS;

ADULT; AGED; BACTEROIDETES; BAYES THEOREM; CLINICAL TRIALS AS TOPIC; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; FIRMICUTES; GASTROINTESTINAL MICROBIOME; HEALTHY VOLUNTEERS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION;

EID: 85007575443     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01965-16     Document Type: Article

References (51)

1. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, Hooper LV, Gordon JI. 2003. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299: 2074-2076. http://dx.doi.org/10.1126/science.1080029.
2. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280. http://dx.doi.org/10.1371/ journal.pbio.0060280.
3. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108(Suppl 1): 4554-4561. http:// dx.doi.org/10.1073/pnas.1000087107.
4. Britton RA, Young VB. 2014. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146: 1547-1553. http://dx.doi.org/10.1053/j.gastro.2014.01.059.
5. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. 2007. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142: 624-631. http://dx.doi.org/10.1001/archsurg.142.7.624.
6. Kelly CP, Lamont JT. 2008. Clostridium difficile-more difficult than ever. N Engl J Med 359: 1932-1940. http://dx.doi.org/10.1056/ NEJMra0707500.
7. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC. 2013. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 173: 1359-1367. http:// dx.doi.org/10.1001/jamainternmed.2013.7056.
8. O’Connor JR, Johnson S, Gerding DN. 2009. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924. http://dx.doi.org/10.1053/j.gastro.2009.02.073.
9. Burns DA, Heeg D, Cartman ST, Minton NP. 2011. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS One 6: e24894. http://dx.doi.org/10.1371/journal.pone .0024894.
10. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. 2012. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 40: 1-8. http://dx.doi.org/10.1016/j.ijantimicag.2012.01.004.
11. Wilcox MH, Fawley WN, Settle CD, Davidson A. 1998. Recurrence of symptoms in Clostridium difficile infection-relapse or reinfection? J Hosp Infect 38: 93-100. http://dx.doi.org/10.1016/S0195-6701(98)90062-7.
12. McFarland LV, Elmer GW, Surawicz CM. 2002. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97: 1769-1775. http://dx.doi.org/10.1111/j.1572-0241.2002.05839.x.
13. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197: 435-438. http://dx.doi.org/10.1086/525047.
14. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. 2010. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44: 354-360. http://dx.doi.org/10.1097/MCG.0b013e3181c87e02.
15. Rolfe RD, Helebian S, Finegold SM. 1981. Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis 143: 470-475. http://dx.doi.org/10.1093/infdis/143.3.470.
16. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MRM, Jenq RR, Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG. 2015. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517: 205-208. http:// dx.doi.org/10.1038/nature13828.
17. Eiseman B, Silen W, Bascom GS, Kauvar AJ. 1958. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44: 854-859.
18. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8: e1002995. http://dx.doi.org/10.1371/journal.ppat.1002995.
19. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. 2012. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 1079-1087. http://dx.doi.org/10.1038/ ajg.2012.60.
20. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. 2012. Stan-dardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 761-767. http://dx.doi.org/10.1038/ajg.2011.482.
21. Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. 2013. High-throughputDNAsequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 4: 125-135. http://dx.doi.org/10.4161/gmic.23571.
22. Shankar V, Hamilton MJ, Khoruts A, Kilburn A, Unno T, Paliy O, Sadowsky MJ. 2014. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome 2: 13. http://dx.doi.org/10.1186/2049-2618-2-13.
23. Weingarden A, González A, Vázquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, Knights D, Unno T, Bobr A, Kang J, Khoruts A, Knight R, Sadowsky MJ. 2015. Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome 3: 10. http://dx.doi.org/10.1186/s40168-015-0070-0.
24. Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M, Surawicz C, Cagle L, Neshatian L, Stollman N, Giovanelli A, Ray A, Smith R. 2016. Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated Clostridium difficile infection: a multicenter experience. J Clin Gastroenterol 50: 398-402. http://dx.doi.org/10.1097/MCG.0000000000000374.
25. Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A. 2015. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 41: 835-843. http://dx.doi.org/10.1111/apt.13144.
26. Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, Weese JS, Collins S, Moayyedi P, Crowther M, Ropeleski MJ, Jayaratne P, Higgins D, Li Y, Rau NV, Kim PT. 2016. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 315: 142-149. http://dx.doi.org/10.1001/jama.2015.18098.
27. Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, Reinert SE, Machan JT, Brandt LJ. 2016. Fecal microbiota transplant prevents recurrence in multiply recurrent C. difficile. Ann Intern Med 165: 609-616. http://dx.doi.org/10.7326/M16-0271.
28. Knights D, Kuczynski J, Charlson ES, Zaneveld J, Mozer MC, Collman RG, Bushman FD, Knight R, Kelley ST. 2011. Bayesian community-wide culture-independent microbial source tracking. Nat Methods 8: 761-763. http://dx.doi.org/10.1038/nmeth.1650.
29. Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo M-J, Vulic M, Ohsumi T, Winkler J, Pindar C, McGovern BH, Pomerantz RJ, Aunins JG, Cook DN, Hohmann EL. 2016. A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection. J Infect Dis 214: 173-181.
30. Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. 2014. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 306: G310-G319. http://dx.doi.org/10.1152/ajpgi.00282.2013.
31. Weingarden AR, Dosa PI, DeWinter E, Steer CJ, Shaughnessy MK, Johnson JR, Khoruts A, Sadowsky MJ. 2016. Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth. PLoS One 11: e0147210. http://dx.doi.org/10.1371/journal.pone.0147210.
32. Kisiela M, Skarka A, Ebert B, Maser E. 2012. Hydroxysteroid dehydrogenases (HSDs) in bacteria: a bioinformatic perspective. J Steroid Biochem Mol Biol 129: 31-46. http://dx.doi.org/10.1016/j.jsbmb.2011.08.002.
33. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. 2010. Short-term antibiotic treatment has differing longterm impacts on the human throat and gut microbiome. PLoS One 5: e9836. http://dx.doi.org/10.1371/journal.pone.0009836.
34. Sadowsky MJ, Khoruts A. 2016. Faecal microbiota transplantation is promising but not a panacea. Nat Microbiol 1: 16015. http://dx.doi.org/10.1038/nmicrobiol.2016.15.
35. Seekatz AM, Aas J, Gessert CE. 2014. Recovery of the gut microbiome following fecal microbiota transplantation. mBio 5: 1-9. http://dx.doi.org/10.1128/mBio.00893-14.
36. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. 2013. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 108: 1620-1630. http://dx.doi.org/10.1038/ajg.2013.257.
37. Damman CJ, Brittnacher MJ, Westerhoff M, Hayden HS, Radey M, Hager KR, Marquis SR, Miller SI, Zisman TL. 2015. Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis. PLoS One 10: e0133925. http://dx.doi.org/10.1371/journal.pone.0133925.
38. Rajilić-Stojanović M, Heilig HGHJ, Tims S, Zoetendal EG, de Vos WM. 2012. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 15: 1146-1159. http://dx.doi.org/10.1111/1462-2920.12023.
39. Ahmed W, Staley C, Sadowsky MJ, Gyawali P, Sidhu JPS, Palmer A, Beale DJ, Toze S. 2015. Toolbox approaches using molecular markers and 16S rRNA gene amplicon data sets for identification of fecal pollution in surface water. Appl Environ Microbiol 81: 7067-7077. http://dx.doi.org/10.1128/AEM.02032-15.
40. Henry R, Schang C, Coutts S, Kolotelo P, Prosser T, Crosbie N, Grant T, Cottam D, O’Brien P, Deletic A, McCarthy D. 2016. Into the deep: evaluation of SourceTracker for assessment of faecal contamination of coastal waters. Water Res 93: 242-253. http://dx.doi.org/10.1016/ j.watres.2016.02.029.
41. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J-M, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65. http:// dx.doi.org/10.1038/nature08821.
42. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75: 7537-7541. http://dx.doi.org/10.1128/AEM.01541-09.
43. Staley C, Gould TJ, Wang P, Phillips J, Cotner JB, Sadowsky MJ. 2015. Evaluation of water sampling methodologies for amplicon-based characterization of bacterial community structure. J Microbiol Methods 114: 43-50. http://dx.doi.org/10.1016/j.mimet.2015.05.003.
44. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig WG, Peplies J, Glöckner FO. 2007. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 35: 7188-7196. http://dx.doi.org/10.1093/nar/gkm864.
45. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194-2200. http://dx.doi.org/10.1093/bioinformatics/btr381.
46. Gihring TM, Green SJ, Schadt CW. 2012. Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. Environ Microbiol 14: 285-290. http://dx.doi.org/10.1111/j.1462-2920.2011.02550.x.
47. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. 2009. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37: D141-D145. http://dx.doi.org/10.1093/nar/gkn879.
48. Bray JR, Curtis JT. 1957. An ordination of the upland forest communities of southern Wisconsin. Ecol Monogr 27: 325-349. http://dx.doi.org/10.2307/1942268.
49. Clarke KR. 1993. Non-parametric multivariate analyses of changes in community structure. Austral Ecol 18: 117-143. http://dx.doi.org/10.1111/j.1442-9993.1993.tb00438.x.
50. Excoffier L, Smouse PE, Quattro JM. 1992. Analysis of molecular variance inferred from metric distances amongDNAhaplotypes-application to human mitochondrial DNA restriction data. Genetics 131: 479-491.
51. Acar EF, Sun L. 2013. A generalized Kruskal-Wallis test incorporating group uncertainty with application to genetic association studies. Biometrics 69: 427-435. http://dx.doi.org/10.1111/biom.12006.